Clinical Trial

The Study on the Efficacy of tDCS Stimulation of the Cerebellum Combined With XingNaoJing Injection in Patients With Consciousness Disorders After Cranial Injury

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to investigate the effect of tDCS stimulation of cerebellum combined with Xingnaojing on patients with disturbance of consciousness after craniocerebral injury, and to clarify the relationship between the following two points: (1) to clarify whether MMN, P300, fNIRS, BAEP, SEP can be used as objective indicators to distinguish VS from MCS. (2) To clarify the changes of consciousness level and brain function in DoC patients with craniocerebral injury treated with tDCS stimulation of cerebellum combined with Xingnaojing.
Trial Details
NCT Number NCT06927336
Lead Sponsor The Second Affiliated Hospital of Kunming Medical University
Conditions tDCS, Cerebellum, Brain Injury, Disturbance of Consciousness
Enrollment 200 participants
Start Date 2025-04-25
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-15